Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$100,000.00

Pushing the limits of visual cortex plasticity: cholinergic enhancement to augment the effects of perceptual learning as a treatment for adult amblyopia

EF 2013-14

Résumé
Amblyopia is one of the most common causes of vision loss in children, affecting 3-5% of the population. Caused by pre-existing conditions in early childhood such as eye misalignment (strabismus), unbalanced vision (anisometropia) or deprivation of visual input (cataract), amblyopia leads to poor vision of the affected eye and loss of stereopsis (3D vision). These deficits are due to abnormal connections in the visual cortex set during early childhood. Amblyopia is often successfully treated in young children by patching the good eye, but it is left untreated in adults because changes made during childhood are thought to be hard-wired and irreversible beyond a 'critical period' of brain development. However, recent studies indicate that treatments that require an active participation by the observer such as perceptual learning can lead to significant improvements in vision of adult amblyopes. While these results are encouraging, it is unknown why perceptual learning works and whether its effects can be enhanced by combining with another approach to boost the brain's capacity for change. Here, we propose to test whether increasing the level of acetylcholine, an excitatory neurotransmitter, using a pharmacological approach can enhance the effects of perceptual learning in adult amblyopia. The drug proposed here is donepezil, one of the most extensively used drugs for the treatment of Alzheimer's disease. Along with measuring vision changes, we will monitor how activities in the visual cortex are changed by perceptual learning alone and in combination with donepezil, using state-of-the-art fMRI imaging techniques. Through this project, we will be able to test whether a combination of perceptual learning and donepezil may be used as a new treatment for adult amblyopia that can be tested in a larger clinical trial. We hope that our research will deepen the current understanding of amblyopia and propose new approaches to make lasting changes in the adult brain.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
301376
Name
Huh Carey Youlim
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Pushing the limits of visual cortex plasticity: cholinergic enhancement to augment the effects of perceptual learning as a treatment for adult amblyopia
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Acetylcholine; Amblyopia; Attention; Donepezil; Functional Magnetic Resonance Imaging; Neural Plasticity; Perceptual Learning; Psychopharmacology; Psychophysics; Visual Cortex
Abstract
Amblyopia is one of the most common causes of vision loss in children, affecting 3-5% of the population. Caused by pre-existing conditions in early childhood such as eye misalignment (strabismus), unbalanced vision (anisometropia) or deprivation of visual input (cataract), amblyopia leads to poor vision of the affected eye and loss of stereopsis (3D vision). These deficits are due to abnormal connections in the visual cortex set during early childhood. Amblyopia is often successfully treated in young children by patching the good eye, but it is left untreated in adults because changes made during childhood are thought to be hard-wired and irreversible beyond a 'critical period' of brain development. However, recent studies indicate that treatments that require an active participation by the observer such as perceptual learning can lead to significant improvements in vision of adult amblyopes. While these results are encouraging, it is unknown why perceptual learning works and whether its effects can be enhanced by combining with another approach to boost the brain's capacity for change. Here, we propose to test whether increasing the level of acetylcholine, an excitatory neurotransmitter, using a pharmacological approach can enhance the effects of perceptual learning in adult amblyopia. The drug proposed here is donepezil, one of the most extensively used drugs for the treatment of Alzheimer's disease. Along with measuring vision changes, we will monitor how activities in the visual cortex are changed by perceptual learning alone and in combination with donepezil, using state-of-the-art fMRI imaging techniques. Through this project, we will be able to test whether a combination of perceptual learning and donepezil may be used as a new treatment for adult amblyopia that can be tested in a larger clinical trial. We hope that our research will deepen the current understanding of amblyopia and propose new approaches to make lasting changes in the adult brain.
Competitiondate
201311
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Huh, Carey Youlim
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~